Experts highlight key themes from the ASCO GI Cancers Symposium, including the growing role of AI and an increased emphasis on patient-centered decision-making.

Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of ...

Jones spoke to MHE after presenting research at the 2026 ASCO Gastrointestinal Cancers Symposium, held Jan. 8-10, in San ...

Colton Jones, M.D., of The University of Texas San Antonio, discusses aspirin for colorectal cancer prevention after presenting research comparing GLP-1s with aspirin at the 2026 ASCO Gastrointestinal ...

The FDA has granted breakthrough therapy designation (BTD) to sofetabart mipitecan (LY4170156) for the treatment of patients ...

Tempus AI's diagnostics segment shows strong pricing power, with Oncology ASP rising from $1,630 to over $2,200. Read why TEM ...

CHENGDU, China, Jan. 16, 2026 /PRNewswire/ -- From January 12 to 15, 2026, the 44th J.P. Morgan Healthcare Conference (JPMHC) was held in San Francisco, California, USA. Dr. Ge Michael, President and ...

The activities of the “Advances in Nuclear Medicine: Precision Imaging and Therapy 2026” Conference were officially launched ...

Ahead of her presentation at JP Morgan, Pharmaceutical Technology spoke with Dr. Jennifer Levin Carter, MD, founder and CEO ...

The event underscores the advanced position held by the Emirate of Abu Dhabi in the healthcare sector and its growing role as ...

KUWAIT CITY, Jan 17: Minister of Health Dr. Ahmad Al-Awadhi announced on Saturday that the Ministry has updated its treatment ...

The FDA has accepted the supplemental Biologics License Application (BLA) for ropeginterferon alfa-2b-njft (Besremi), a ...